Clinical Trials Browser

Breast Neoplasms

Cervical Esophagus Adenocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Elderly Metastatic Colorectal Cancer Patients

Neoplasm Metastasis

Stomach Neoplasms

Rectal Neoplasms

Neoplasms, Pancreatic Neoplasms

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

Rectal Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Rectal Cancer Patients

Pancreatic Neoplasms

Esophageal Neoplasms

Stomach Neoplasms

Breast Neoplasms

Anatomic Stage IV Breast Cancer AJCC v8

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Colorectal Neoplasms

Adenocarcinoma

Locally Advanced Rectal Cancer

Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Locally Advanced Colorectal Cancer

Rectal Neoplasms

Breast Neoplasms

Adenocarcinoma, Carcinoma, Rectal Neoplasms, Colorectal Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Childhood Solid Tumor

Rectal Neoplasms

Breast Neoplasms

Pathologic Complete Response

Rectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Neoplasm, Residual, Triple Negative Breast Neoplasms

Colonic Neoplasms

Colonic Neoplasms

Neoplasm Metastasis, Neoplasms

Gastrointestinal Neoplasms

Nasopharyngeal Carcinoma

Pathologic Complete Response, Rectal Neoplasms

Rectal Neoplasms

Nasopharyngeal Carcinoma

Breast Neoplasms

Brain Neoplasms, Glioblastoma, Recurrence

Breast Neoplasms, Meningeal Neoplasms

Breast Neoplasms

Colorectal Neoplasms

Triple Negative Breast Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Clinical Trials

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

COBRA

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

T-DXd_HER2Low

ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

EVOLVE-BDT

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

LAP100

LyRICX

Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma

Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Toco-CoR

A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC

TORCH-iTNT

Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance

Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

JAZMINE

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

PLANET

Metro-PD1

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

MEND-IT II

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

COLOCROSS

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

TRIUNITE-08

Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer

EMPOWER

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

MECCA

Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study

SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study

Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer

TARMAC

CHIMERA